Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone

• Conditions: HIV Infections; HIV-Associated Lipodystrophy Syndrome

• Registration Number: NCT00662181
• Lead Sponsor: Hvidovre University Hospital

Brief Summary

A follow-up study on the randomized, controlled, double-blind HIGH: low study. We will examine the participants from the HIGH: low study min. 6 months after finishing the HIGH: low study. We will look at the parameters: quality of life, sugar-metabolism, fat-metabolism, fat-redistribution and cytokines. The study will use the participants control visit, and the only additional examination will be the danish MOS-HIV questionnaire.

Detailed Description

Not available

Study Timeline

• Status Verified: 2008-04
• Study First Submitted: 2008-04-16
• Study First Submitted QC: 2008-04-18
• Last Update Submitted: 2008-04-18
• Study First Posted: 2008-04-21
• Last Update Posted: 2008-04-21
• Study Start: 2008-05
• Primary Completion: 2008-10
• Study Completion: 2009-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Male
• Target Recruitment: 46

Inclusion Criteria

• over 18 years of age
• Participated in and completed the HIGH: low study
• informed consent signed

Exclusion Criteria

• Patient stopped at Hvidovre Hospital, or didn't finish the HIGH: low study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life	6 months follow-up

Secondary Outcome Measures

Name	Time	Method
Metabolism	6 months follow-up

Trial Locations

Locations (1)

Klinisk Forskningscenter, Hvidovre Hospital; 🇩🇰 Hvidovre, Denmark